Drug Discovery

SAMDI Tech Inc. Awarded Phase I Small Business Innovation Research Grant From NIH

June 19, 2018

Chicago, June 19, 2018 (Business Wire) – SAMDI Tech Inc., the industry’s leading provider of label-free drug discovery solutions, is pleased to announce it has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop the first cell-based and label-free, high-throughput assay of specific enzyme activities.   Funding […]

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

June 18, 2018

SHANGHAI, June 15, 2018: STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its partner, Ascletis has received approval from the National Drug Administration of China (CNDA, former CFDA) of its Category 1 new drug, Ganovo® (also known as Danoprevir or ASC08), to treat viral hepatitis C. The collaboration between WuXi STA and […]

‘Process innovation needs to be undertaken in early R&D phase’ – predicts ADC Bio

June 4, 2018

4 June 2018, Wales: ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and streamline production processes of ADCs will be designed at the clinical development stage by specialist, ADC focused service providers. At present, a number of the larger CDMOsare focused solely on commercial scale ADC production and lack both the […]

FEEDBACK